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Abstract: Oxysterol-binding protein (OSBP) and its homologs designated OSBP-related 
(ORP) or OSBP-like (OSBPL) proteins constitute a conserved family of lipid binding/transfer 
proteins (LTP) in eukaryotes. The mechanisms of ORP function have remained incompletely 
understood, but they have been implicated as intracellular sterol sensors or transporters.  
A number of studies have provided evidence for the roles of ORPs at membrane contact 
sites (MCS), where endoplasmic reticulum is closely apposed with other organelle limiting 
membranes. ORPs are postulated to either transport sterols over MCSs or control the 
activity of enzymatic effectors or assembly of protein complexes with functions in signaling 
and lipid metabolism. Studies of yeast Saccharomyces cerevisiae ORPs Osh4p, Osh3p, 
Osh6p and Osh7p have revealed that ORPs do not exclusively bind sterols within their 
OSBP-related ligand-binding domain (ORD): The Osh4p ORD accommodates either 
sterols or phosphatidylinositol-4-phosphate (PI4P), and the Osh3p ORD was shown to 
specifically bind PI4P, the binding cavity being too narrow for a sterol to fit in. Most recently, 
Osh6p and Osh7p were demonstrated to show specific affinity for phosphatidylserine (PS), 
and to play a role in the intracellular transport of this glycerophospholipid; Additionally, 
two mammalian ORPs were shown to bind PS. Thus, the term frequently used for 
ORPs/OSBPLs, oxysterol-binding proteins, is a misnomer. While a number of ORPs bind 
oxysterols or cholesterol, other family members appear to interact with phospholipid ligands to 
regulate lipid fluxes, organelle lipid compositions and cell signaling. As a conclusion, 
ORPs are LTPs with a wide ligand spectrum and marked functional heterogeneity. 
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1. Introduction 
The compartmentalization of lipid synthetic processes and the inter-organelle distributions of lipids 
in eukaryotic cells necessitate well controlled lipid fluxes [1]. The intracellular transport of lipids is 
mediated by four major mechanisms: (i) Flip-flop from one leaflet of a bilayer to the other [2,3];  
(ii) movement as components of transport vesicles/tubular carriers [4,5]; (iii) diffusion along 
membrane bilayers and between closely apposed membrane leaflets [1], (iv) transfer by lipid 
binding/transfer proteins (LTPs) [6,7]. The latter two mechanisms represent non-vesicular inter-bilayer 
lipid transport and play important roles in lipid fluxes between organelles not connected via the 
established pathways of membrane trafficking. The markedly hydrophobic nature of most membrane 
lipids makes their diffusion through the aqueous cytosolic phase energetically unfavourable. Therefore, 
non-vesicular lipid transfer necessitates either close proximity of the two membranes and/or the 
involvement of LTPs that carry a bound lipid across the aqueous phase [7]. Membrane contact sites 
(MCS) are zones of close apposition (10–30 nm distance) of endoplasmic reticulum (ER) membranes 
with other organelle limiting membranes. These contact sites have established or postulated roles in 
lipid syntheses, inter-organelle lipid transport, Ca2+ signaling, and ER function [8–11]. 
Cholesterol is the most abundant single lipid molecular species in mammalian cells. It plays a 
central role in controlling the fluidity, permeability, and microdomain organization of specific 
membrane bilayers, as well as the activity of a number of membrane-associated proteins [12]. 
Cholesterol displays an uneven distribution in cellular membranes, being enriched towards late Golgi 
and the PM, as well as in endosomal compartments. The mechanisms maintaining this asymmetry are 
not perfectly understood, but partitioning of cholesterol into laterally organized domains together with 
sphingolipids and glycerophospholipids with a high degree of fatty acyl chain saturation is suggested 
to play an important role [13,14]. Cholesterol is markedly hydrophobic, and even though part of it is 
transported within cells along with vesicular/tubular carriers of the vesicle transport pathways, its 
efficient inter-organelle transport needs to be mediated to a large extent by non-vesicular processes 
facilitated e.g., by LTPs and/or closely apposed membrane domains, similar to the transport of glycero- and 
sphingolipids with physiologic, long-chain fatty acyl chains [7,15,16]. Oxysterols, 27-carbon oxygenated 
derivatives of cholesterol, are formed by enzymatic or non-enzymatic oxidative processes [17,18], and 
are present in healthy tissues in trace amounts as compared to cholesterol [19,20]. Oxysterols differ 
quite significantly from cholesterol in their biophysical properties, such as their orientation in bilayers, 
impacts on membrane lipid packing as well as their increased solubility and high rate of spontaneous 
inter-membrane transport [21–24]. The latter property prompts the question of whether carrier proteins 
are necessary for the inter-organelle transport of oxysterols, or whether spontaneous transfer is 
sufficient to account for the observed rapid movement. When accumulating in pathologic tissues, 
oxysterols display adverse, cytotoxic effects [25–29]; However, a number of endogenous cellular 
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oxysterols, especially those modified by hydroxylation of the sterol side chain, have crucial signaling 
functions via liganding of transcription factors and protein regulators of metabolism [20,30]. 
2. OSBP-Related Proteins and Their Liganding by Sterols 
Oxysterol-binding protein family members, designated OSBP-related (ORP) or OSBP-like (OSBPL) 
proteins, are LTPs characterized by a carboxy-terminal OSBP-related ligand-binding (ORD) domain; 
In addition, most of them have a pleckstrin homology (PH) domain in their N-terminal part, involved 
in membrane targeting of the proteins, and either a short amino acid motif (FFAT, two phenylalanines 
in an acidic tract) or a C-terminal trans-membrane span specifying association of the proteins with ER 
membranes [31–35] (Figure 1). In mammals the protein family is encoded by 12 genes [31,34,35], 
while in yeast Saccharomyces cerevisiae there are seven ORP genes/proteins designated OSBP 
homologs (Osh; [32]). The ORDs of a number of ORPs were found to accommodate a variety of 
oxysterols, cholesterol, or ergosterol [33,36]. The hallmark study of Im et al. [33] reported the  
high-resolution structure of yeast Osh4p complexed with five different sterols. This study revealed a  
β-barrel like fold with a lipid-binding cavity, in which the bound sterol is oriented with its 3β-hydroxyl 
group facing the bottom of the pocket (Figure 1). 
Figure 1. Schematic structure of ORP proteins. ORD, OSBP-related ligand binding domain, 
represents human ORP1 ORD modeled by using the yeast Osh4p structure [33] as a 
template. Bound sterol, which stabilizes a closed conformation of a flexible ‘Lid’ structure, 
is depicted as a gray ball-model. β-strands are displayed as flat arrows and α-helical 
secondary structures as helices. While “Short” subtype ORPs, such as yeast Osh4p-Osh7p, 
consist of a mere ORD, the “Long” subtype family members (most mammalian ORPs belong 
to this category) carry an N-terminal extension (blue) with a pleckstrin homology (PH) 
domain interacting with phosphoinositides and a short peptide motif (two phenylalanines in 
an acidic tract, FFAT) that targets the ER. 
 
Bound sterol stabilizes a closed conformation of a lid composed of a 2-stranded β-sheet and three  
α-helices, which makes contacts with the sterol iso-octyl side chain. Non-sterol bound Osh4p could not 
be crystallized, apparently due to an unorganized state of the lid. The lid-open Osh4p was suggested to 
expose basic amino acid residues near the mouth of the ligand cavity that interact with phosphate 
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groups at membrane surfaces, thus facilitating sterol extraction from the bilayer. Studies in yeast have 
provided evidence for a function of Osh4p and other yeast ORPs in sterol transport from the PM to the 
ER [37,38]; However, contradicting findings rather suggesting function of the Osh proteins as 
modifiers of the lateral organization of sterol at the PM have been reported [39]. 
OSBP, the prototype mammalian ORP, binds 25-hydroxycholesterol (25OHC) with a Kd of 10 nM, 
the affinity for other oxysterols being lower. OSBP also binds cholesterol, with a Kd of 170 nM [40–44]. 
The other human ORPs thus far studied display different affinities for various oxysterols, with Kds in the 
nM-μM range [43,45,46], and like OSBP, several of them are also suggested to bind cholesterol [45,47,48]. 
Considering that the cellular concentration of cholesterol vastly exceeds that of oxysterols, one could 
argue that cholesterol may be a more relevant physiologic ligand of these proteins than oxysterols [33]. 
However, oxysterols are markedly more aqueous soluble than cholesterol, which may greatly increase 
their accessibility for binding into the ORD. While oxysterol binding in vitro by purified ORPs has 
been demonstrated for OSBP, ORP4 (subfamily I), ORP1, ORP2 (subfamily II), and in vitro sterol 
transfer activity shown for OSBP, ORP9L, and the ORD of ORP5 [49,50], as well as the yeast  
S. cerevisiae ORPs Osh2p, Osh4p, and Osh5p (and a weaker activity for Osh1p, Osh3p) [37,38], the 
ligand binding properties of most ORPs (including the human proteins) have not been studied in detail. 
A study employing photo-cross-linkable cholesterol and 25OHC reported a positive cross-linking 
signal for either or both of these sterols for a total of human 10 ORPs [46]. In this study it remained, 
however, to some extent unclear whether all signals were due to sterol insertion within the ORD 
binding cavity, or if some of them may reflect cross-linking of the sterol derivatives to the surface of 
proteins associated peripherally or integrally with cell membranes. 
3. ORPs Can Bind Glycerophospholipids 
The extraction of sterols by Osh4p was shown to be markedly enhanced by inclusion of 
phosphatidylinositol-4,5-bisphosphate (PIP2) in the donor vesicles. Moreover, PIP2 as well as another 
acidic glycerophospholipid, phosphatidylserine (PS), in the donors were found to facilitate the 
transport of cholesterol from one vesicle population to another [37]. Such transfer stimulation was 
interpreted to reflect interactions of Osh4p with the charged membrane surface, facilitating its 
membrane docking and extraction of sterol from the bilayer, as suggested by Im et al. [33]. 
Intriguingly, however, Osh4p was also able to extract PIP2 from vesicles and displayed significant 
inter-vesicle transfer of this lipid [37], suggesting that PIP2 could actually be extracted from the 
membrane and be fully or partially inserted into the ligand cavity within the Osh4p ORD. Further work 
by Schulz et al. [38] identified on the ORD of Osh4p two membrane binding surfaces, one near the 
mouth of the ligand binding cavity and another distally located. The authors provided evidence 
suggesting that Osh4p employs these interaction surfaces to associate with two membranes 
simultaneously to catalyze inter-membrane sterol transfer. 
De Saint-Jean et al. [51] determined the structure of Osh4p crystallized with PI4P inserted in the 
ORD pocket, and showed that a bound sterol (dehydroergosterol, DHE) is readily exchanged for PI4P. 
The authors suggested, based on in vitro evidence, that the two lipids could be transported by Osh4p in 
opposite directions in cells, i.e. sterol from the ER to the trans-Golgi/PM and PI4P backwards. This 
attractive model could explain how an increasing sterol gradient from the ER to the PM [12,13,52] is 
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generated and why OSH4 disruption in yeast results in a phenotypic bypass of mutations in other genes 
reducing late secretory pathway PI4P levels [53,54]. 
Mousley et al. [55] reported that a sterol-binding deficient mutant osh4/kes1Y97F characterized by 
Alfaro et al. [56] disturbs cell proliferation due to its enhanced PI4P-dependent association with  
trans-Golgi network (TGN) and endosomes, thus representing a gain-of-function. The data strongly 
suggested that binding of sterol by Osh4p has a negative regulatory role, detaching the protein from 
TGN/endosome membranes [55], rather than a sterol transport function. The Osh4p-mediated growth 
arrest was in part due to amino acid deficiencies caused by defects in the trafficking of amino acid 
permeases, suppression of gene expression driven by Gcn4, a transcriptional activator of the general 
amino acid control (GAAC) regulon, and disturbed target of rapamycin complex 1 (TORC1) signaling. 
The TGN/endosomal signal generated by Osh4p remained incompletely understood, but it could 
involve sphingolipid enrichment in TGN/endosome membranes, a hypothesis supported by the study 
of LeBlanc et al. [57] who observed sphingolipid deficiencies in Osh4p-depleted yeast cells.  
The above studies are incompatible with a simple function of Osh4p as a sterol and PI4P transporter, 
but rather suggest a complex role in TGN/endosomal PI4P/sphingolipid signaling, with impacts on 
multiple cellular functions. 
Tong et al. [58] recently solved the structure of the Osh3p ORD with bound PI4P (Figure 2).  
The structure revealed that the ligand cavity is too narrow to accommodate bulky 4-ringed sterol 
molecules, strongly suggesting that Osh3p has no capacity of sterol binding. Of note, the authors 
pinpointed at the entrance of the ligand cavity a cleft that accommodates the phosphoinositol moiety of 
PI4P, and indicated that amino acid residues lining this cleft are highly conserved among all ORPs. 
This interesting observation, together with related findings by De Saint-Jean et al. [51], brought up the 
possibility that PI4P binding could be a unifying feature of all ORPs, and that only a subset of the 
family members could additionally be capable of accommodating sterol ligands. 
The perception of ORP ligand specificity was further complicated by the latest report by Maeda  
et al. [59] showing that yeast Osh6p and Osh7p specifically bind PS, extract this phospholipid from 
membranes, and that disruption of osh6/osh7 in yeast cells results in a defect of PS transport from the 
ER to the PM, as determined by imaging with a Lact C2-GFP probe. Osh6p was crystallized, and PS 
was modeled into the ORD ligand cavity: The head group and the unsaturated sn-2 fatty acyl chain 
were oriented towards the entrance of the pocket, while a saturated sn-1 chain pointed towards the 
bottom of the cavity. Interestingly, the functional defect in osh6−/osh7− cells appeared specific for the 
ER-PM transport step, since the authors, consistent with the earlier data of Raychaudhuri et al. [37], 
found no defect in conversion of PS to PE and PC, a process that involves non-vesicular transport of 
PS to mitochondria or the Golgi complex where PS decarboxylases are located [16]. Of note, Osh6p 
extracted no or very little ergosterol from membranes, suggesting that it, similar to Osh3p (see above), 
may be unable to bind sterols, thus putatively belonging to a new, PS-preferring ORP subgroup. In the 
light of these findings, the mechanisms resulting in the distortions in ergosterol metabolism in OSH6 
deletion or overexpressing yeast strains reported by Wang et al. [60] remain subject of further study. 
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Figure 2. The yeast Osh3p ORD binds phosphatidylinositol-4-phosphate. (A) Binding of 
PI4P in the ORD. The two fatty acyl chains are inserted in the central hydrophobic tunnel, 
and the phosphoinositol head group is accommodated in a shallow basic cleft at the tunnel 
entrance. (B) The hydrophobic tunnel. The amino acid residues composing the wall of the 
tunnel are shown as ball-and-stick models. Reprinted with permission from Tong et al. [58] 
Copyright (2013) Elsevier Ltd. 
 
Sequence analyses by Maeda et al. [59] suggested that among mammalian ORPs, ORP5, 8, 9, 10 
and 11 belong to the same clade as Osh6p. Consistently, the ORDs of human ORP5 and 10 were 
shown to extract PS from liposomes. Some caution, however, is appropriate in interpreting in vitro 
lipid binding data obtained using fusion proteins produced in E. coli: Partial misfolding of recombinant 
proteins may expose regions with artefactual affinity for distinct lipids. The report of Maeda et al. [59], 
together with the observations by De Saint-Jean et al. [51] and Tong et al. [58], emphasized the idea 
that a number of ORPs could mediate the non-vesicular transport of phospholipids such as PS, PI4P, 
and possibly PIP2 [37]. This hypothesis would be consistent with the earlier observations that yeast 
Osh proteins are not essential for ergosterol transport from the ER to the PM [39], and that a subset of 
these proteins (Osh1p, Osh3p, Osh6, Osh7p) display in vitro very weak sterol transfer activity [38]. 
The lipid ligands of human and yeast ORPs identified by structural analyses or ligand binding/transfer 
assays employing purified proteins are summarized in Table 1. 
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Table 1. Ligands identified for the ORDs of human and Saccharomyces cerevisiae ORPs 
by structural analyses or in vitro binding/transport assays. 
Protein ORD ligand(s) Reference(s) 
Homo sapiens 
OSBP 25OHC 1, 20OHC, 7KC 2, 22(R)OHC, 22(S)OHC, 7OHC,  
cholesterol + other oxysterols specified in [42] 
[40,42–44] 
ORP4/OSBP2 25OHC, 20OHC, 22(S)OHC, 7OHC, 7KC, 22(R)OHC, cholesterol [43,61] 
ORP1 24(S)OHC, 22(R)OHC, 7KC, 25OHC, cholesterol [46,48] 
ORP2 22(R)OHC, 7KC, 25OHC, cholesterol [45,46] 
ORP3 ?  
ORP5 Dehydroergosterol, cholesterol?, PS 3 [49,59] 
ORP6 ?  
ORP7 ?  
ORP8 25OHC?, cholesterol [62,63] 
ORP9 Cholesterol [50] 
ORP10 Cholesterol, PS [47,59] 
ORP11 ?  
Saccharomyces cerevisiae 
Osh1p Cholesterol? [38] 
Osh2p Cholesterol [38] 
Osh3p PI4P 4, cholesterol? [38,58] 
Osh4p Ergosterol, cholesterol, 7OHC, 20OHC, 25OHC, dehydroergosterol, 
PI4P, PIP2? PS? 
[33,37,51] 
Osh5p Cholesterol [38] 
Osh6p PS [59] 
Osh7p PS [59] 
1 hydroxycholesterol, 2 ketocholesterol, 3 phosphatidylserine, 4 phosphatidylinositol-4-phosphate. 
4. Function of ORPs at Membrane Contact Sites 
The capacity of most ORPs to target both the ER and other, non-ER organelle membranes, together 
with the observed localization of the yeast ORP Osh1p at a membrane contact site, the nucleus-vacuole 
junction [64,65], prompted the idea that these proteins could execute functions at MCSs [66]. This 
concept has gained increasing experimental support in both yeast and mammalian cells. Four yeast 
ORPs, Osh2p, Osh3p, Osh6p and Osh7p, were reported to be enriched at the cortical ER or ER-PM 
contacts [38,60]. Stefan et al. [67] provided convincing evidence that yeast Osh3p acts to recruit the 
PI4P phosphatase Sac1p anchored at ER membranes, at sites where it has access to its substrate PI4P 
on the PM. The data thus suggested a function of Osh3p as an organizer of functional protein 
complexes at ER-PM MCSs, with potential impacts on PM signal transduction and vesicle transport. In 
the light of the localization of Osh6p and Osh7p at ER-PM contact zones [38], the observations of 
Maeda et al. [59] on a functional role of these proteins in PS transport to the PM suggest that they 
could be part of a MCS-localized machinery responsible for flipping newly synthesized PS from the 
ER to the PM. The PM-associated ER domains in yeast are reported to have high PS synthetic activity [68]. 
One is therefore tempted to speculate that PS binding Osh proteins could be strategically located to 
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couple PS synthesis to immediate transfer of this aminophospholipid to its destination, the cytoplasmic 
leaflet of the PM. Here, ORPs could function analogously to the ceramide transporter (CERT) which, 
according to accumulating evidence, acts at ER-trans-Golgi contact sites to flip ceramides 
accommodated within its START domain, to Golgi for sphingomyelin synthesis [69]. Models on the 
function of yeast Osh proteins are depicted in Figure 3. 
Figure 3. Models for the functions of yeast Osh proteins. (A) Osh4p acts at an ER-PM 
contact site, employs two membrane binding surfaces to associate with the bilayers via 
interactions with phosphoinositides (PIP) and other phospholipids, and transfers sterols (S) 
from one membrane to another [38]. (B) Osh6p and Osh7p transfer phosphatidylserine 
(PS) from the ER to the PM at membrane contact sites [59]. (C) Osh4p binds sterols (S) 
and phosphatidylinositol-4-phosphate (PI4P) in an exchange-type fashion within the same 
pocket, and transfers these two lipids in opposite directions [51]. (D) Osh4p binds to 
membranes of the trans-Golgi network and endosomes via interactions with PI4P. This 
association has a signaling function, and is negatively regulated by sterol binding to Osh4p, 
which detaches the protein from membranes [55]. (E) Osh3p acts at an ER-PM contact site, 
where it interacts with ER VAP proteins (Scs2p and -22p) through its two phenylalanines 
in an acidic tract (FFAT) motif and with PIPs via both its pleckstrin homology (PH) 
domain and the ORD ligand-binding tunnel, which accommodates PI4P. Osh3p controls 
the activity of the PI4P phosphatase Sac1p, an integral ER membrane protein, towards its 
substrate PI4P at the PM [58,67]. 
 
Among the mammalian ORPs, the presence of determinants specifying both ER association and 
targeting to other organelles implicates putative functions at MCSs [36]. Factual evidence for a  
MCS-associated function has been reported for ORP1L, which interacts with ER VAP proteins 
through its FFAT motif and with the late endosomal (LE) small GTPase Rab7 via its N-terminal 
ankyrin repeat domain [70]. Upon cellular cholesterol depletion or expression of sterol-binding 
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deficient mutant ORP1L, ORP1L-positive LE become scattered and display increased association with 
ER membranes, reflecting elevated affinity for the ER VAP proteins [48,71]. In contrast, knock-down 
of ORP1L increases the overall motility of LE, and mutation of the ORP1L FFAT motif mediating 
binding to VAPs in the ER has a similar effect [48]. When sterol is abundant, the sterol-bound 
conformation of ORP1L detaches from the ER and a tripartite complex of Rab7, ORP1L, and a second 
Rab7 effector, RILP (Rab7 interacting lysosomal protein) recruits dynein-dynactin motors on the LE 
surface, resulting in microtubule minus end-directed movement of LE towards the microtubule-organizing 
center [71,72]. The latest report provides evidence that ORP1L acts as a sterol-controlled switch regulating 
the interactions of RILP with dynactin and the homotypic vacuole fusion and protein sorting (HOPS) 
complex, which mediates organelle/transport vesicle docking on LE/lysosomes [73]. Thus, ORP1L 
controls the motility and subcellular distribution of LE as well as the docking/fusion of 
vesicles/organelles in the late endocytic pathway, with impacts on both protein transport and the 
cellular efflux of endocytosed cholesterol [48]. Of interest, and possibly related to the function of 
ORP1L, Du et al. [49] reported that ORP5, a protein integrally anchored to ER membranes, can be  
co-immunoprecipitated with the late endosomal cholesterol egress factor Niemann-Pick C1 (NPC1), 
and ORP5 knock-down resulted in accumulation of cholesterol in the limiting membrane of LE.  
The authors suggested that ORP5 might act at ER-LE contacts to mediate direct routing of endosomal 
cholesterol to the ER for esterification, a hypothesis awaiting further experimental dissection. They 
also provided in vitro evidence that the ORD of ORP5 is able to transfer cholesterol, indicating that the 
ligand-binding cavity of ORP5 may have the capacity to bind both sterol and PS [59]. 
5. Conclusions 
The prevailing view has been that ORPs/OSBPLs function as sterol sensors relaying information to 
machineries responsible for different aspects of cell regulation, or as sterol transporters. We have 
envisioned that, via action as sterol and phosphoinositide sensors at organelle interfaces, ORPs 
modulate the lipid compositions of specific organelle membranes and the assembly of effector protein 
complexes, with impacts on signaling, vesicle transport, and lipid metabolism [36]. The report of 
Raychaudhuri et al. [37] produced the first indications suggesting that ORPs could, in addition to 
sterols, bind and transport glycerophospholipids. De Saint-Jean et al. [51] demonstrated that yeast 
Osh4p binds both sterols and PI4P, and can exchange the bound ligand. The authors provided evidence 
that Osh4p could transport the two lipids in opposite directions. However, the work of Mousley et al. [55] 
rather suggested that Osh4p binds to TGN and endosomal membranes via PI4P, with impacts on 
secretory membrane trafficking and metabolic control, and that this membrane association is 
negatively regulated by sterol binding. Recent work by Tong et al. [58] provided evidence that yeast 
Osh3p binds PI4P but not sterols, due to the limited dimensions of its ligand binding cavity, and that 
the ability to bind PI4P may be a property conserved among all or most ORPs. Maeda et al. [59] 
produced structural and functional evidence for the closely related Osh6p and Osh7p acting as PS 
transporters, and that also human ORP5 and 10 have the capacity to bind PS. This hallmark report 
supported the early findings of Raychaudhuri et al. [37] and the conclusion of Tong et al. [58] that the 
ORDs of ORPs are not confined to sterol liganding, but ORPs actually are LTPs with a wide spectrum 
of lipidous ligands, executing heterogeneous cellular functions. Thus, the term frequently used for the 
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entire protein family, oxysterol-binding proteins, is a misnomer. While acting as sensors mediating 
lipid signals is definitely one aspect of ORP activity, their roles in controlling intracellular lipid fluxes 
and organelle lipid compositions should be addressed systematically, in order to reach a 
comprehensive understanding of this highly conserved protein family. 
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